Our aim is to continue the nationwide endeavor to reduce the burden of atopic disease and to improve the well-being of those with asthma, atopic dermatitis, and IgE-mediated allergies. The main aims are linked to the Finnish Allergy Programme and are as follows (Figures 1 and 2):

​

1. Study the epidemiology of atopic diseases and allergic sensitization profiles in Finland.

2. Measure the burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland.

3. Evaluate and improve the current use of diagnostic tests for atopic diseases.

4. Evaluate the use and effectiveness of allergen immunotherapy in real world setting.

5. Assess the direct and indirect costs related to atopic diseases and comorbidities.

​

Our overarching objective is the comprehensive scrutiny of the prevalence, concurrent comorbidities, diagnostic modalities, therapeutic interventions, and the holistic impact of diverse atopic diseases. We will uncover previously unexplored factors contributing to the development of atopic diseases and their associated coexisting conditions. Ultimately, our mission is to develop innovative approaches that advance diagnostic precision, enhance therapeutic interventions, curtail costs, and implement preventative measures to arrest the progression of these multifaceted conditions.